{
    "id": 20,
    "premise": "none",
    "hypothesis": "Dasatinib may be effective in treating this patient.",
    "label": "entailment",
    "explanation": "This patient has an activating mutation in CTNNB1.\nDasatinib may be effective in treating CTNNB1 mutations.\nDrugs targeting the Wnt pathway are not available for this patient.\nThis treatment is not available for this patient.\nPatient will have to travel, may not be suitable.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "Dasatinib may be effective in treating this patient.",
        "refined explanation": "This patient has an activating mutation in CTNNBDasatinib may be effective in treating CTNNB1 mutations.\nDrugs targeting the Wnt pathway are not available for this patient.\nThis treatment is not available for this patient.\nPatient will have to travel, may not be suitable.\nPatients with activating mutations in CTNNB1 may respond to Dasatinib treatment.",
        "refined iteration": 1,
        "history explanation": [
            "0 iteration: This patient has an activating mutation in CTNNB1.\nDasatinib may be effective in treating CTNNB1 mutations.\nDrugs targeting the Wnt pathway are not available for this patient.\nThis treatment is not available for this patient.\nPatient will have to travel, may not be suitable.",
            "1 iteration: This patient has an activating mutation in CTNNBDasatinib may be effective in treating CTNNB1 mutations.\nDrugs targeting the Wnt pathway are not available for this patient.\nThis treatment is not available for this patient.\nPatient will have to travel, may not be suitable.\nPatients with activating mutations in CTNNB1 may respond to Dasatinib treatment."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Since the patient has an activating mutation in CTNNB1, we can conclude that Dasatinib may be effective in treating this patient. *)\\nthen have \"\u2203e. Effective e \u2227 Agent e x \u2227 Agent e y\" sledgehammer', 'solving time': 119.27788233757019, 'proof tactics': [], 'code': 'theory clinical_20_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Has :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Drugs :: \"entity \u21d2 bool\"\\n  Pathway :: \"entity \u21d2 bool\"\\n  Wnt :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n  NotAvailable :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Travel :: \"event \u21d2 bool\"\\n  NotSuitable :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Patient x \u2227 Mutation y \u2227 Activating y \u2227 CTNNB1 z \u2227 Has e \u2227 Agent e x \u2227 Agent e y \u2227 In y z\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Dasatinib x \u2227 Mutation y \u2227 CTNNB1 z \u2227 Effective e \u2227 Agent e x \u2227 Agent e y \u2227 In y z\"\\n\\n(* Explanation 3: Drugs targeting the Wnt pathway are not available for this patient. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e. Drugs x \u2227 Pathway y \u2227 Wnt y \u2227 Patient z \u2227 Targeting e \u2227 Agent e x \u2227 Agent e y \u2227 NotAvailable e \u2227 For e z\"\\n\\n(* Explanation 4: This treatment is not available for this patient. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y e. Treatment x \u2227 Patient y \u2227 NotAvailable e \u2227 Agent e x \u2227 For e y\"\\n\\n(* Explanation 5: Patient will have to travel, may not be suitable. *)\\naxiomatization where\\n  explanation_5: \"\u2203x e1 e2. Patient x \u2227 Travel e1 \u2227 Agent e1 x \u2227 NotSuitable e2 \u2227 Agent e2 x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x \u2227 Patient y\"\\n  (* Hypothesis: Dasatinib may be effective in treating this patient. *)\\n  shows \"\u2203x y e. Dasatinib x \u2227 Patient y \u2227 Effective e \u2227 Agent e x \u2227 Agent e y\"\\nproof -\\n  (* From the premise, we have known information about Dasatinib and the patient. *)\\n  from asm have \"Dasatinib x \u2227 Patient y\" <ATP>\\n  (* Explanation 2 states that Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  (* We can use this information to infer that Dasatinib may be effective for the patient with CTNNB1 mutation. *)\\n  from explanation_2 have \"\u2203x y z e. Dasatinib x \u2227 Mutation y \u2227 CTNNB1 z \u2227 Effective e \u2227 Agent e x \u2227 Agent e y \u2227 In y z\" <ATP>\\n  (* Since the patient has an activating mutation in CTNNB1, we can conclude that Dasatinib may be effective in treating this patient. *)\\n  then have \"\u2203e. Effective e \u2227 Agent e x \u2227 Agent e y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: patient has an activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: Dasatinib may be effective in treating CTNNB1 mutations (from Explanatory Sentence 2)\\nC: drugs targeting the Wnt pathway are available for this patient (from Explanatory Sentence 3)\\nD: this treatment is available for this patient (from Explanatory Sentence 4)\\nE: patient will have to travel (from Explanatory Sentence 5)\\nF: treatment may not be suitable (from Explanatory Sentence 5)\\n\\nLogical Relations:\\nNot(C)\\nNot(drugs targeting the Wnt pathway are available for this patient)\\n--------\\nNot(D)\\nNot(this treatment is available for this patient)\\n--------\\nImplies(E, F)\\nImplies(patient will have to travel, treatment may not be suitable)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(treatment may not be suitable), Not(this treatment is available for this patient))\\n--------\\nImplies(C, Not(E))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(patient will have to travel))\\n--------\\nImplies(C, E)\\nImplies(drugs targeting the Wnt pathway are available for this patient, patient will have to travel)\\n--------\\nImplies(F, Not(C))\\nImplies(treatment may not be suitable, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(patient will have to travel), Not(this treatment is available for this patient))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(this treatment is available for this patient), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(E, Not(C))\\nImplies(patient will have to travel, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(C, Not(F))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(treatment may not be suitable))\\n--------\\nImplies(F, Not(D))\\nImplies(treatment may not be suitable, Not(this treatment is available for this patient))\\n--------\\nImplies(C, F)\\nImplies(drugs targeting the Wnt pathway are available for this patient, treatment may not be suitable)\\n--------\\nImplies(D, Not(E))\\nImplies(this treatment is available for this patient, Not(patient will have to travel))\\n--------\\nImplies(E, Not(D))\\nImplies(patient will have to travel, Not(this treatment is available for this patient))\\n--------\\nImplies(D, E)\\nImplies(this treatment is available for this patient, patient will have to travel)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(drugs targeting the Wnt pathway are available for this patient), Not(this treatment is available for this patient))\\n--------\\nImplies(C, D)\\nImplies(drugs targeting the Wnt pathway are available for this patient, this treatment is available for this patient)\\n--------\\nImplies(C, Not(D))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(this treatment is available for this patient))\\n--------\\nImplies(Not(F), Not(C))\\nImplies(Not(treatment may not be suitable), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, Not(F))\\nImplies(this treatment is available for this patient, Not(treatment may not be suitable))\\n--------\\nImplies(D, Not(C))\\nImplies(this treatment is available for this patient, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, F)\\nImplies(this treatment is available for this patient, treatment may not be suitable)\\n--------\\nImplies(Not(E), Not(C))\\nImplies(Not(patient will have to travel), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, C)\\nImplies(this treatment is available for this patient, drugs targeting the Wnt pathway are available for this patient)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 7.98833441734314, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'verit found a proof...', 'cvc4 found a proof...', 'vampire found a proof...', 'e found a proof...', 'verit: Try this: using assms explanation_2 by blast (1 ms)', 'zipperposition: Try this: using explanation_2 explanation_3 by blast (6 ms)', 'e: Found duplicate proof', 'cvc4: Found duplicate proof', 'zipperposition found a proof...', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'zipperposition: Found duplicate proof', 'Done'], 'code': 'theory clinical_20_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Patient :: \"entity \u21d2 bool\"\\n  Mutation :: \"entity \u21d2 bool\"\\n  Activating :: \"entity \u21d2 bool\"\\n  Has :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  CTNNB1 :: \"entity \u21d2 bool\"\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Drugs :: \"entity \u21d2 bool\"\\n  Targeting :: \"event \u21d2 bool\"\\n  Pathway :: \"entity \u21d2 bool\"\\n  Wnt :: \"entity \u21d2 bool\"\\n  NotAvailable :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  Treatment :: \"entity \u21d2 bool\"\\n  Travel :: \"event \u21d2 bool\"\\n  NotSuitable :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: This patient has an activating mutation in CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Patient x \u2227 Mutation y \u2227 Activating y \u2227 Has e \u2227 Agent e x \u2227 In y z \u2227 CTNNB1 z\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating CTNNB1 mutations. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. Dasatinib x \u2227 Mutation y \u2227 CTNNB1 y \u2227 Effective e \u2227 Agent e x\"\\n\\n(* Explanation 3: Drugs targeting the Wnt pathway are not available for this patient. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y e. Drugs x \u2227 Targeting e \u2227 Agent e x \u2227 Pathway y \u2227 Wnt y \u2227 NotAvailable e \u2227 Patient z \u2227 For e z\"\\n\\n(* Explanation 4: This treatment is not available for this patient. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y e. Treatment x \u2227 Patient y \u2227 NotAvailable e \u2227 Agent e x \u2227 For e y\"\\n\\n(* Explanation 5: Patient will have to travel, may not be suitable. *)\\naxiomatization where\\n  explanation_5: \"\u2203x e1 e2. Patient x \u2227 Travel e1 \u2227 Agent e1 x \u2227 NotSuitable e2 \u2227 Agent e2 x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x \u2227 Patient y\"\\n  (* Hypothesis: Dasatinib may be effective in treating this patient. *)\\n  shows \"\u2203x y e. Dasatinib x \u2227 Patient y \u2227 Effective e \u2227 Agent e x\"\\nproof -\\n  (* From the premise, we have known information about Dasatinib and the patient. *)\\n  from asm have \"Dasatinib x \u2227 Patient y\" <ATP>\\n  (* Explanation 1 provides that the patient has an activating mutation in CTNNB1. *)\\n  from explanation_1 have \"\u2203x y z e. Patient x \u2227 Mutation y \u2227 Activating y \u2227 Has e \u2227 Agent e x \u2227 In y z \u2227 CTNNB1 z\" <ATP>\\n  (* Explanation 2 states that Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  from explanation_2 have \"\u2203x y e. Dasatinib x \u2227 Mutation y \u2227 CTNNB1 y \u2227 Effective e \u2227 Agent e x\" <ATP>\\n  (* Using the logical relation Implies(A, B), we can infer that Dasatinib may be effective in treating CTNNB1 mutations. *)\\n  then have \"Dasatinib x \u2227 Effective e \u2227 Agent e x\" <ATP>\\n  (* Combine with the known information about the patient. *)\\n  then have \"Dasatinib x \u2227 Patient y \u2227 Effective e \u2227 Agent e x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: patient has an activating mutation in CTNNB1 (from Explanatory Sentence 1)\\nB: Dasatinib may be effective in treating CTNNB1 mutations (from Explanatory Sentence 1)\\nC: drugs targeting the Wnt pathway are available for this patient (from Explanatory Sentence 2)\\nD: this treatment is available for this patient (from Explanatory Sentence 3)\\nE: patient will have to travel (from Explanatory Sentence 4)\\nF: travel may not be suitable (from Explanatory Sentence 4)\\nG: patients with activating mutations in CTNNB1 may respond to Dasatinib treatment (from Explanatory Sentence 5)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(patient has an activating mutation in CTNNB1, Dasatinib may be effective in treating CTNNB1 mutations)\\n--------\\nNot(C)\\nNot(drugs targeting the Wnt pathway are available for this patient)\\n--------\\nNot(D)\\nNot(this treatment is available for this patient)\\n--------\\nImplies(E, F)\\nImplies(patient will have to travel, travel may not be suitable)\\n--------\\nImplies(A, G)\\nImplies(patient has an activating mutation in CTNNB1, patients with activating mutations in CTNNB1 may respond to Dasatinib treatment)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(travel may not be suitable), Not(this treatment is available for this patient))\\n--------\\nImplies(C, Not(E))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(patient will have to travel))\\n--------\\nImplies(D, Not(B))\\nImplies(this treatment is available for this patient, Not(Dasatinib may be effective in treating CTNNB1 mutations))\\n--------\\nImplies(Not(A), Not(D))\\nImplies(Not(patient has an activating mutation in CTNNB1), Not(this treatment is available for this patient))\\n--------\\nImplies(C, Not(A))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(patient has an activating mutation in CTNNB1))\\n--------\\nImplies(Not(G), Not(C))\\nImplies(Not(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(C, A)\\nImplies(drugs targeting the Wnt pathway are available for this patient, patient has an activating mutation in CTNNB1)\\n--------\\nImplies(C, E)\\nImplies(drugs targeting the Wnt pathway are available for this patient, patient will have to travel)\\n--------\\nImplies(C, B)\\nImplies(drugs targeting the Wnt pathway are available for this patient, Dasatinib may be effective in treating CTNNB1 mutations)\\n--------\\nImplies(G, Not(C))\\nImplies(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(F, Not(C))\\nImplies(travel may not be suitable, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(Not(B), Not(D))\\nImplies(Not(Dasatinib may be effective in treating CTNNB1 mutations), Not(this treatment is available for this patient))\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(patient will have to travel), Not(this treatment is available for this patient))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(this treatment is available for this patient), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, G)\\nImplies(this treatment is available for this patient, patients with activating mutations in CTNNB1 may respond to Dasatinib treatment)\\n--------\\nImplies(B, Not(C))\\nImplies(Dasatinib may be effective in treating CTNNB1 mutations, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(E, Not(C))\\nImplies(patient will have to travel, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(Not(G), Not(D))\\nImplies(Not(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment), Not(this treatment is available for this patient))\\n--------\\nImplies(G, Not(D))\\nImplies(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment, Not(this treatment is available for this patient))\\n--------\\nImplies(F, Not(D))\\nImplies(travel may not be suitable, Not(this treatment is available for this patient))\\n--------\\nImplies(C, Not(F))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(travel may not be suitable))\\n--------\\nImplies(A, Not(C))\\nImplies(patient has an activating mutation in CTNNB1, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(C, F)\\nImplies(drugs targeting the Wnt pathway are available for this patient, travel may not be suitable)\\n--------\\nImplies(C, Not(G))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment))\\n--------\\nImplies(D, Not(A))\\nImplies(this treatment is available for this patient, Not(patient has an activating mutation in CTNNB1))\\n--------\\nImplies(D, Not(E))\\nImplies(this treatment is available for this patient, Not(patient will have to travel))\\n--------\\nImplies(B, Not(D))\\nImplies(Dasatinib may be effective in treating CTNNB1 mutations, Not(this treatment is available for this patient))\\n--------\\nImplies(E, Not(D))\\nImplies(patient will have to travel, Not(this treatment is available for this patient))\\n--------\\nImplies(D, E)\\nImplies(this treatment is available for this patient, patient will have to travel)\\n--------\\nImplies(D, A)\\nImplies(this treatment is available for this patient, patient has an activating mutation in CTNNB1)\\n--------\\nImplies(D, B)\\nImplies(this treatment is available for this patient, Dasatinib may be effective in treating CTNNB1 mutations)\\n--------\\nImplies(Not(C), Not(D))\\nImplies(Not(drugs targeting the Wnt pathway are available for this patient), Not(this treatment is available for this patient))\\n--------\\nImplies(C, Not(B))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(Dasatinib may be effective in treating CTNNB1 mutations))\\n--------\\nImplies(A, Not(D))\\nImplies(patient has an activating mutation in CTNNB1, Not(this treatment is available for this patient))\\n--------\\nImplies(C, D)\\nImplies(drugs targeting the Wnt pathway are available for this patient, this treatment is available for this patient)\\n--------\\nImplies(C, Not(D))\\nImplies(drugs targeting the Wnt pathway are available for this patient, Not(this treatment is available for this patient))\\n--------\\nImplies(Not(F), Not(C))\\nImplies(Not(travel may not be suitable), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(C, G)\\nImplies(drugs targeting the Wnt pathway are available for this patient, patients with activating mutations in CTNNB1 may respond to Dasatinib treatment)\\n--------\\nImplies(Not(A), Not(C))\\nImplies(Not(patient has an activating mutation in CTNNB1), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, Not(F))\\nImplies(this treatment is available for this patient, Not(travel may not be suitable))\\n--------\\nImplies(D, Not(C))\\nImplies(this treatment is available for this patient, Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, F)\\nImplies(this treatment is available for this patient, travel may not be suitable)\\n--------\\nImplies(Not(B), Not(C))\\nImplies(Not(Dasatinib may be effective in treating CTNNB1 mutations), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(Not(E), Not(C))\\nImplies(Not(patient will have to travel), Not(drugs targeting the Wnt pathway are available for this patient))\\n--------\\nImplies(D, Not(G))\\nImplies(this treatment is available for this patient, Not(patients with activating mutations in CTNNB1 may respond to Dasatinib treatment))\\n--------\\nImplies(D, C)\\nImplies(this treatment is available for this patient, drugs targeting the Wnt pathway are available for this patient)\\n--------\\n'}"
        ]
    }
}